FDA

Dr. Robert Califf, President Joe Biden’s pick to head the Food and Drug Administration, has prescribed cannabinoid therapy as a cardiac doctor and actively encourages research into cannabinoid medicine.

Louisiana is set to allow Delta-8 THC in food and other edible products following an announcement this week by the state’s Department of Health.

California now allows for hemp-derived cannabinoids in everyday products including food and beverages, dietary supplements, cosmetics, and pet food.

The Washington State Liquor and Cannabis Board has released a draft proposal that would further regulate “psychotropic” and “impairing” cannabinoids like Delta-8 and Delta-10 THC.

The FDA and CDC issued warnings this week against consumer products containing hemp-derived delta-8 THC, which has yet to be thoroughly studied.

The U.S. Food and Drug Administration has denied two applications from companies seeking to sell CBD hemp extracts as a dietary supplement because CBD is an approved drug.

The FDA has announced plans to ban flavored tobacco products including menthol cigarettes and flavored cigars.

The FTC and FDA have launched “Operation CBDeceit,” sending fines and warning letters to CBD companies who allegedly made false or misleading health claims about their products.

The FDA announced it is hiring a third-party contractor to test CBD “and related cannabinoids” for the agency.

The FDA has expanded the label of Epidiolex, the first CBD-based medication approved by the federal agency, to treat seizures resulting from tuberous sclerosis complex.

The FDA has opened public comments for new preliminary guidance from the agency for cannabis pharmaceutical research.

The FTC has filed a rare lawsuit against CBD company Whole Leaf Organics over unfounded treatment claims made by the company.

Summitt Labs announced last week it was voluntarily recalling Batch#730 Lot#K018 of its Kore Organic Watermelon CBD Oil Tincture.

The FDA has issued warnings to two CBD companies over claims that their products could treat opioid addiction and/or replace pharmaceutical drugs.

The Hemp Feed Coalition is submitting an application to get hemp approved as chicken feed by the FDA; the process could take 18 months or longer.

Lawmakers questioned officials from the DEA, FDA, and National Institutes of Health yesterday about the federal limitations on cannabis research; Rep. Joe Kennedy III (D-MA) accused the government agencies of hiding behind a cannabis “Catch-22.”

A new FDA consumer update claims that CBD “has the potential to harm” and suggests that symptoms could range from potential mood swings to even male infertility.

Senate Majority Leader Mitch McConnell recently met with FDA Commissioner nominee Dr. Stephen Hahn and discussed the need for a federal CBD regulatory framework.

The FDA has approved a human trials study by the Yale School of Medicine and CT Pharma investigating the effectiveness of cannabis-based medicines; it’s the first cannabis study on human subjects to be approved by the FDA.

Researchers at Johns Hopkins University announced last week the formation of what is likely the world’s largest research facility dedicated to psilocybin and psychedelic medicinal research.

Washington state Ag Department officials recently clarified that hemp-derived CBD is not allowed as a food additive.

FDA officials say they will rush the release of federal CBD rules and regulations, potentially by the end of summer or early fall.

Three weeks after its first public hearing on cannabidiol, the FDA says it will apply a “rigorous and science-based approach” to devising CBD regulations; however, despite the quickly growing marketplace, the agency has not yet set any official guidelines.

Grocery store chain Kroger has begun selling CBD topicals at its stores in 17 states, joining a growing trend of traditional corporate retailers who are embracing CBD products since hemp was federally legalized last year.